Ultrasound antenatal diagnosis in epileptic women on valproic acid;Diagnostic antenatal echographique chez la mere epileptique sous acide valproique: Etude retrospective de 161 cas du Registre France/Centre-Est de malformations congenitales

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 27, Issue 4, 1998, Pages 413-419

  Bradai R ^a   Robert, E ^b  

^a HÔTEL DIEU   (France)

^b Institut Europeen des Genomutations   (France)

Author keywords

Malformations; Pregnancy; Ultrasound; Valproic acid

Indexed keywords

VALPROIC ACID; ANTICONVULSIVE AGENT;

ARTICLE; CLEFT LIP; CONGENITAL HEART MALFORMATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EPILEPSY; FEMALE; FETUS ECHOGRAPHY; FETUS MALFORMATION; HUMAN; HYPOSPADIAS; LIMB MALFORMATION; PREGNANCY; SPINA BIFIDA; TERATOGENICITY; CONGENITAL MALFORMATION; ECHOGRAPHY; FRANCE; HEALTH SURVEY; PREGNANCY COMPLICATION; REGISTER; RETROSPECTIVE STUDY;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; FEMALE; FRANCE; HUMANS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL; VALPROIC ACID;

EID: 0032084484     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985; 152: 499-504.
2. Weber M. Médicaments anti-épileptiques et tératogenèse. Rev Neurol 1987;143:413-9.
3. Durner M, Greenberg DA, Delgado-Escueta AV. Is there a genetic relationship between epilepsy and birth defects ? Neurology 1992;42(S5):63-7.
4. Robert E. Risques tératogènes de l'épilepsie et des antiépileptiques. Pédiatrie 1991;46:579-83.
5. Dravet C, Julian C, Legras C, Magaudda A, Guerrini R, Genton P et al. Epilepsy, antiepileptic drugs, and malformations in children of epileptic women : a French prospective cohort study. Neurology 1992;42(S5):75-82.
6. Kaneko S, Otani K, Kondo T, Fukushima Y, Nakamura Y, Ogawa Y et al. Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. Neurology 1992;42(S5): 68-74.
7. Koch S, Lösche G, Jager-Roman E, Jakob S, Rating O, Deichl A et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992;42(S5):83-8.
8. Bethenod M, Fréderich A. Les enfants des antiépileptiques. Pédiatrie 1975;30:227-48.
9. Robert E, Guibaud P. Maternal valproic acid and congenital neural-tube defects. Lancet 1982;2:937.
10. Koren G, Edwards MB, Miskin M. Antenatal sonography of fetal malformations associated with drugs and chemicals : a guide. Am J Obstet Gynecol 1987;156:79-85.
11. Robert E, Francannet C, Robert JM. Le registre de malformations de la région Rhône-Alpes/Auvergne. J Gynecol Obstet Biol Reprod 1988;17:601-7.
12. Favre R. Valeur diagnostique de l'échographie dans les malformations fœtales. In : Mise à jour en gynécologie obstétrique. Paris: Vigol, 1994:81-93.
13. Copel JA, Pilu G, Kleinman S. Congenital heart disease and extracardiac anomalies : associations and indications for fetal echocardiography. Am J Obstet Gynecol 1986;154: 1121-32.
14. Levy S, Hyjazi Y, Schaaps JP, Defoort P, Coulon R, Buekens P. Sensitivity and specificity of routine antenatal screening for congenital anomalies by ultrasound : the Belgian multicentric study. Ultrasound Obstet Gynecol 1991;1:102-10.
15. Omtzigt JG, Los FJ, Hagenaars AM, Stewart PA, Sachs ES, Lindhout D. Prenatal diagnosis of spina bifida aperta after first trimester Valproate exposure. Prenat Diagn 1992;12: 893-7.
16. Omtzigt JG, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 1992;42(S5):119-25.
17. Robert E, Robert JM. L'acide valproïque est-il tératogène ? Rev Neurol 1983;139:445-7.
18. Campbell S, Pryse-Davies J, Coltart TM, Seller MJ, Singer JD. Ultrasound in the diagnosis of spina bifida. Lancet 1975;1:1065-8.
19. Henrion R, Bourgeois J, Coicaud C, Jaubert De Beaujeu M, Louis D, Plauchu H et al. Table ronde : apport de l'échographie au diagnostic anténatal de malformations curables ou non curables. Rev Fr Gynécol Obstet 1983;78:383-404.
20. Brodaty G. Fentes labiales et associations malformatives diagnostiquées par échographie. Soir Echo Gyn Obst, Ed Milupa, 1989;57:17-21.
21. Saltzman DH, Benacerraf BR, Frigoletto FD. Diagnosis and management of fetal facial clefts. Am J Obstet Gynecol 1986;155:377-9.
22. Benacerraf BR, Figoletto FD Jr, Bieber FR. The fetal face ultrasound examination. Radiology 1984; 153:495-7.
23. Favre R, Grandjean H, Nisand I. Signes d'appel échographiques de la trisomie 21, in mise à jour en gynécologie obstétrique. Paris, Vigot 1991:327-47.
24. Sharony R, Garber A, Viskochil D, Schreck R, Platt LD, Ward R et al. Preaxial ray reduction defects as part of valproic acid embryofetopathy. Prenat Diagn 1993;13:909-18.
25. Ylagan LR, Budorick NE. Radial ray aplasia in utero : a prenatal finding associated with valproic acid exposure. J Ultrasound Med 1994;13:408-11.
26. Buntinx IM. Preaxial polydactyly in the fetal valproate syndrome. Eur J Pediat 1992;151:919-20.
27. Jager-Roman E, Deichl A, Jakob S, Hartmann S, Rating D, Steldinger R et al. Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108:997-1004.
28. Langer B, Haddad J, Gasser B, Maubert M, Schlaeder G. Isolated fetal bilateral radial ray reduction associated with valproic acid usage. Fetal Diagn Ther 1994;9:155-8.
29. Okada T, Tomoda T, Hisakawa H, Kurashige T. Fetal valproate syndrome with reduction deformity of limb. Acta Paediat Jpn 1995;37:58-60.
30. Collet M, Le Guem H, Boog G. Anomalies des membres. In : Echographie des malformations fœtales, Gillet JY. Paris : Vigot, 1990:263-301.
31. Escobar LF, Bixler F, Padilla LM, Weaver DD. Fetal craniofacial morphometrics : in utero evaluation at 16 weeks'gestation. Obstet Gynecol 1988;72:674-9.